Get the Stockscreener App
45.60
4.19%
1.9749
Veracyte Inc stock is traded at $45.60, with a volume of 525.30K.
It is up +4.19% in the last 24 hours and up +1.90% over the past month.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
See More
Previous Close:
$43.63
Open:
$43.41
24h Volume:
525.30K
Relative Volume:
0.60
Market Cap:
$3.61B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-60.81
EPS:
-0.75
Net Cash Flow:
$40.13M
1W Performance:
+7.52%
1M Performance:
+1.90%
6M Performance:
+65.25%
1Y Performance:
+4.72%
1-Day Range:
$43.41
$45.69
1-Week Range:
$41.48
$45.69
52-Week Range:
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
45.65 | 3.45B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
622.22 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.74 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.85 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.15 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.96 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Underweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Hold |
| Mar-20-25 | Initiated | Craig Hallum | Buy |
| Dec-05-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Here's Why You Should Retain Masimo Stock in Your Portfolio Now - Finviz
Guggenheim Raises Price Target for Veracyte (VCYT) to $50.00 | V - GuruFocus
Veracyte price target raised to $50 from $45 at Guggenheim - TipRanks
Morgan Stanley initiates coverage of Veracyte, Inc. (VCYT) - MSN
Veracyte (VCYT): Assessing Whether Recent Momentum Justifies Its Current Valuation - Yahoo Finance
The Truth About Veracyte Inc (VCYT): Silent Biotech Stock That Could Blow Up Your Portfolio - AD HOC NEWS
Yousif Capital Management LLC Takes Position in Veracyte, Inc. $VCYT - MarketBeat
Investment Review: How interest rate cuts could boost Veracyte Inc stock2025 Trade Ideas & Safe Entry Zone Tips - moha.gov.vn
Smart Oncology: 5 Stocks Chasing the $317B Prize - Cantech Letter
Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT) - Yahoo Finance
Zacks Industry Outlook Highlights Veracyte, IDEXX Laboratories and Intuitive Surgical - sharewise.com
Is This the Right Time to Add Veracyte Stock to Your Portfolio? - Eastern Progress
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference - 01net
3 Medical Instrument Stocks to Counter Industry Woes Using GenAI - sharewise.com
12 Best Genomics Stocks to Invest In - Insider Monkey
Veracyte (NASDAQ:VCYT) Raised to Strong-Buy at Wall Street Zen - MarketBeat
Is this the right time to add Veracyte stock to your portfolio? - MSN
Veracyte, Inc. $VCYT Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Published on: 2025-12-25 21:43:38 - moha.gov.vn
What analysts say about Veracyte Inc stockFundamental Stock Analysis & Crush the Market with Breakout Winners - earlytimes.in
Veracyte Earnings Notes - Trefis
Why Veracyte Inc. (12V) stock remains top rated2025 Pullback Review & High Accuracy Swing Trade Signals - Улправда
How Veracyte Inc. stock benefits from global expansion2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - Улправда
How analysts rate Veracyte Inc. stock todayCPI Data & Safe Swing Trade Setup Alerts - Улправда
Layoff Watch: Is Veracyte Inc. stock a top pick in earnings seasonTrade Performance Summary & Daily Profit Focused Stock Screening - Улправда
Is Veracyte Inc. stock a top pick in earnings season2025 Price Momentum & Trade Opportunity Analysis - Улправда
Why Veracyte Inc. stock could outperform in 20252025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - DonanımHaber
Will Veracyte Inc. stock gain from lower inflationMarket Performance Recap & Technical Confirmation Alerts - Bölüm Sonu Canavarı
What analyst consensus says on Veracyte Inc. stockWeekly Gains Summary & Smart Swing Trading Alerts - DonanımHaber
Fed Meeting: Why Veracyte Inc. stock could outperform in 2025Short Setup & Target Return Focused Stock Picks - DonanımHaber
Will Veracyte Inc. stock attract more institutional investorsWeekly Stock Summary & Low Drawdown Momentum Ideas - Улправда
Can Veracyte Inc. stock weather global recessionMarket Growth Summary & Low Risk Profit Maximizing Plans - Улправда
Can Veracyte Inc. stock deliver strong Q4 earningsIPO Watch & Detailed Earnings Play Strategies - Улправда
CEO Change: Is Veracyte Inc. stock a top pick in earnings seasonDividend Hike & Accurate Trade Setup Notifications - Улправда
Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 30% Discount? - Yahoo Finance
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) SVP Sells $463,173.07 in Stock - MarketBeat
Veracyte Executive Sells Shares Under Pre-arranged Trading Plan - TradingView — Track All Markets
Veracyte (VCYT) SVP & General Counsel reports insider stock sale - Stock Titan
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Veracyte, Inc. $VCYT Shares Sold by Nikko Asset Management Americas Inc. - MarketBeat
Craig-Hallum Initiates Coverage of Veracyte (VCYT) with Buy Recommendation - MSN
Veracyte (NASDAQ:VCYT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Morgan Stanley Maintains Veracyte (VCYT) Underweight Recommendation - MSN
First Trust Advisors LP Raises Holdings in Veracyte, Inc. $VCYT - MarketBeat
PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor - sharewise.com
Next Century Growth Investors LLC Lowers Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
JPMorgan Chase & Co. Buys 243,111 Shares of Veracyte, Inc. $VCYT - MarketBeat
Arrowstreet Capital Limited Partnership Sells 165,322 Shares of Veracyte, Inc. $VCYT - MarketBeat
Eastham (Veracyte director) sells $908k in VCYT stock By Investing.com - Investing.com Canada
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):